Kevin W McConeghy
Overview
Explore the profile of Kevin W McConeghy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1039
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McConeghy K, Davidson H, Canaday D, Han L, Hayes K, Baier R, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2452677.
PMID: 39745702
Importance: Influenza vaccination remains the most important intervention to prevent influenza morbidity and mortality among nursing home residents. The additional effectiveness of recombinant influenza vaccine vs standard dose vaccines was...
2.
Garbin A, DeVone F, Bayer T, Stevens-Lapsley J, Abul Y, Singh M, et al.
J Am Med Dir Assoc
. 2024 Jun;
25(9):105120.
PMID: 38945171
Objectives: Examine physical function change and physical therapy (PT) use in short-stay and long-stay residents not infected by CoVID-19 within Veterans Affairs (VA) Community Living Centers (CLCs). Design: Retrospective cohort...
3.
Singh M, DeVone F, Bayer T, Abul Y, Garbin A, Leeder C, et al.
J Am Med Dir Assoc
. 2024 Jun;
25(8):105101.
PMID: 38906176
Objective: Wandering behavior in nursing home (NH) residents could increase risk of infection. The objective of this study was to assess the association of wandering behavior with SARS-CoV-2 infection in...
4.
Gravenstein S, DeVone F, Oyebanji O, Abul Y, Cao Y, Chan P, et al.
EBioMedicine
. 2024 Jun;
105:105180.
PMID: 38861869
Background: Bivalent SARS-CoV-2 vaccines were developed to counter increasing susceptibility to emerging SARS-CoV-2 variants. We evaluated the durability of immunity and protection following first bivalent vaccination among nursing home residents....
5.
McConeghy K, Hur K, Dahabreh I, Jiang R, Pandey L, Gellad W, et al.
Clin Infect Dis
. 2024 Feb;
78(3):625-632.
PMID: 38319989
Background: Vaccine hesitancy persists alongside concerns about the safety of coronavirus disease 2019 (COVID-19) vaccines. We aimed to examine the effect of COVID-19 vaccination on risk of death among US...
6.
Gillespie C, Sitter K, McConeghy K, Strymish J, Gupta K, Hartmann C, et al.
J Allergy Clin Immunol Pract
. 2023 Jun;
11(9):2848-2854.e3.
PMID: 37352930
Background: Unconfirmed penicillin allergies are common and may contribute to adverse outcomes, especially in frail older patients. Evidence-based clinical pathways for evaluating penicillin allergies have been effectively and safely applied...
7.
Gravenstein S, DeVone F, Oyebanji O, Abul Y, Cao Y, Chan P, et al.
medRxiv
. 2023 May;
PMID: 37163130
Background: Vaccines have substantially mitigated the disproportional impact of SARS-CoV-2 on the high morbidity and mortality experienced by nursing home residents. However, variation in vaccine efficacy, immune senescence and waning...
8.
Gantenberg J, McConeghy K, Howe C, Steingrimsson J, van Aalst R, Chit A, et al.
Am J Epidemiol
. 2023 May;
192(10):1688-1700.
PMID: 37147861
Accurate forecasts can inform response to outbreaks. Most efforts in influenza forecasting have focused on predicting influenza-like activity, with fewer on influenza-related hospitalizations. We conducted a simulation study to evaluate...
9.
Abul Y, DeVone F, Singh M, Halladay C, Bayer T, McConeghy K, et al.
R I Med J (2013)
. 2023 Apr;
106(4):25-29.
PMID: 37098143
Objectives: This study aimed to better understand Class II/III obesity prevalence trends among older adults residing in nursing homes (NH) nationwide. Methods: Our retrospective cross-sectional study evaluated Class II/III obesity...
10.
Canaday D, Oyebanji O, White E, Bosch J, Nugent C, Vishnepolskiy I, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Jan;
72(4):100-106.
PMID: 36701254
Introduction of monovalent COVID-19 mRNA vaccines in late 2020 helped to mitigate disproportionate COVID-19-related morbidity and mortality in U.S. nursing homes (1); however, reduced effectiveness of monovalent vaccines during the...